Page last updated: 2024-08-21

isoxazoles and Abnormalities, Drug-Induced

isoxazoles has been researched along with Abnormalities, Drug-Induced in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (23.53)18.2507
2000's8 (47.06)29.6817
2010's5 (29.41)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beck, E; Schaefer, C; Tissen-Diabaté, T; Weber-Schoendorfer, C1
Cagnoli, GA; Cassina, M; Clementi, M; Di Gianantonio, E; Zuccarello, D1
Fukushima, R; Hirashiba, M; Hishikawa, A; Kanamori, S; Kaneto, M; Kitagawa, H; Muranaka, R2
Chambers, CD1
Braddock, SR; Cassina, M; Chambers, CD; Jimenez, JL; Johnson, DL; Jones, KL; Luo, YJ; Mirrasoul, N; Robinson, LK; Salas, E; Xu, R1
Engeland, A; Furu, K; Viktil, KK1
Ohtahara, S; Yamatogi, Y2
Badgwell, C; Rosen, T1
Chambers, C; Johnson, D; Jones, KL; Koren, G; Tutuncu, ZN1
Amano, Y; Egawa, I; Kaneko, S; Kondo, T1
Koren, G; Kozer, E; Moretti, ME1
Chambers, CD; Johnson, DL; Lyons Jones, K1
Martson', LV; Nedopitnskaia, NN; Shepel'skaia, NR1
Fujii, S; Furukawa, S; Haguro, S; Morinaga, T; Morino, K; Toteno, I; Yamakita, O1
Fuchigami, K; Kodama, R; Matsunaga, K; Otsuka, T; Sameshima, K; Yamakita, O1

Reviews

2 review(s) available for isoxazoles and Abnormalities, Drug-Induced

ArticleYear
Cutaneous sarcoidosis therapy updated.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:1

    Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Allopurinol; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antigen Presentation; Antimalarials; Chlorambucil; Contraindications; Cyclosporine; Cytokines; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Laser Therapy; Leflunomide; Male; Melatonin; Methotrexate; Models, Immunological; Pentoxifylline; Pregnancy; Pregnancy Complications; Sarcoidosis; Skin Diseases; Tetracyclines; Th1 Cells; Thalidomide

2007
Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study.
    Canadian family physician Medecin de famille canadien, 2007, Volume: 53, Issue:3

    Topics: Abnormalities, Drug-Induced; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Incidence; Information Services; Isoxazoles; Leflunomide; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Risk Assessment; Sulfasalazine; Teratogens

2007

Other Studies

15 other study(ies) available for isoxazoles and Abnormalities, Drug-Induced

ArticleYear
Leflunomide - A human teratogen? A still not answered question. An evaluation of the German Embryotox pharmacovigilance database.
    Reproductive toxicology (Elmsford, N.Y.), 2017, Volume: 71

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Antirheumatic Agents; Arthritis, Rheumatoid; Esophageal Atresia; Female; Germany; Humans; Infant, Newborn; Isoxazoles; Leflunomide; Male; Maternal-Fetal Exchange; Pharmacovigilance; Pregnancy; Pregnancy Trimester, First; Teratogens; Tracheoesophageal Fistula; Young Adult

2017
Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
    European journal of medical genetics, 2017, Volume: 60, Issue:1

    Topics: Abnormalities, Drug-Induced; Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Fetal Diseases; Fetus; Fluconazole; Humans; Isoxazoles; Leflunomide; Mutation; Mycophenolic Acid; Phenotype; Pregnancy; Teratogenesis; Teratogens; Thalidomide; Warfarin

2017
Inhibiting the teratogenicity of the immunosuppressant leflunomide in mice by supplementation of exogenous uridine.
    Toxicological sciences : an official journal of the Society of Toxicology, 2009, Volume: 108, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Dihydroorotate Dehydrogenase; Embryonic Development; Female; Fetal Viability; Fetus; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Mice, Inbred ICR; Oxidoreductases Acting on CH-CH Group Donors; Pregnancy; Pyrimidine Nucleotides; Teratogens; Uridine

2009
Critical periods for the teratogenicity of immune-suppressant Leflunomide in mice.
    Congenital anomalies, 2009, Volume: 49, Issue:1

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adjuvants, Immunologic; Animals; Critical Period, Psychological; Embryo Loss; Embryo, Mammalian; Female; Fetal Viability; Gestational Age; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mice; Mice, Inbred ICR; Pregnancy

2009
Value of the small cohort study including a physical examination for minor structural defects in identifying new human teratogens.
    Congenital anomalies, 2011, Volume: 51, Issue:1

    Topics: Abnormalities, Drug-Induced; Anticonvulsants; Antidepressive Agents; Arthritis, Rheumatoid; Carbamazepine; Case-Control Studies; Cohort Studies; Female; Fever; Fluoxetine; Humans; Isoxazoles; Leflunomide; Maternal Exposure; Neural Tube Defects; Physical Examination; Pregnancy; Prospective Studies; Research Design; Teratogens; Tretinoin

2011
Pregnancy outcome in women exposed to leflunomide before or during pregnancy.
    Arthritis and rheumatism, 2012, Volume: 64, Issue:7

    Topics: Abnormalities, Drug-Induced; Antirheumatic Agents; Chondrodysplasia Punctata; Ductus Arteriosus, Patent; Ectodermal Dysplasia; Female; Heart Block; Humans; Isoxazoles; Leflunomide; Pierre Robin Syndrome; Pregnancy; Pregnancy Outcome; Prospective Studies; Rheumatic Diseases; Spina Bifida Occulta

2012
Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
    Scandinavian journal of rheumatology, 2012, Volume: 41, Issue:3

    Topics: Abnormalities, Drug-Induced; Adalimumab; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cohort Studies; Databases, Factual; Drug Utilization Review; Etanercept; Fathers; Female; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Mothers; Norway; Pregnancy; Pregnancy Outcome; Receptors, Tumor Necrosis Factor; Registries; Risk Factors; Young Adult

2012
Safety of zonisamide therapy: prospective follow-up survey.
    Seizure, 2004, Volume: 13 Suppl 1

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Incidence; Infant; Isoxazoles; Male; Mental Disorders; Middle Aged; Product Surveillance, Postmarketing; Zonisamide

2004
Erratum to "Safety of zonisamide therapy: prospective follow-up survey.".
    Seizure, 2007, Volume: 16, Issue:1

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Incidence; Infant; Isoxazoles; Male; Mental Disorders; Middle Aged; Product Surveillance, Postmarketing; Zonisamide

2007
Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy.
    Epilepsia, 1996, Volume: 37, Issue:12

    Topics: Abnormalities, Drug-Induced; Adult; Anencephaly; Anticonvulsants; Epilepsy; Female; Humans; Infant, Newborn; Isoxazoles; Polypharmacy; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Risk Factors; Zonisamide

1996
Leflunomide: new antirheumatic drug. Effect on pregnancy outcomes.
    Canadian family physician Medecin de famille canadien, 2001, Volume: 47

    Topics: Abnormalities, Drug-Induced; Adult; Arthritis, Rheumatoid; Female; Half-Life; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Pregnancy; Pregnancy Complications

2001
Monitoring leflunomide (Arava) as a new potential teratogen.
    Teratology, 2002, Volume: 65, Issue:5

    Topics: Abnormalities, Drug-Induced; Arthritis, Rheumatoid; Female; Humans; Infant, Newborn; Isoxazoles; Leflunomide; Pregnancy; Teratogens

2002
[An experimental study of carcinogenic activity of bucide and its effects on the reproductive function].
    Gigiena i sanitariia, 1991, Issue:4

    Topics: Abnormalities, Drug-Induced; Animals; Embryo, Mammalian; Female; Fungicides, Industrial; Gonads; Isoxazoles; Male; Neoplasms, Experimental; Pregnancy; Rats; Reproduction

1991
[Reproductive and developmental toxicity study of mofezolac (N-22) (2)--Study by oral administration of N-22 during the period of fetal organogenesis in rats].
    The Journal of toxicological sciences, 1990, Volume: 15 Suppl 2

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Coccyx; Embryonic and Fetal Development; Female; Gestational Age; Isoxazoles; Pregnancy; Rats; Rats, Inbred Strains; Reproduction; Sternum

1990
[Reproductive and developmental toxicity study of mofezolac (N-22) (3)--Teratogenicity study in rabbits by oral administration].
    The Journal of toxicological sciences, 1990, Volume: 15 Suppl 2

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Embryonic and Fetal Development; Female; Fetal Resorption; Gestational Age; Isoxazoles; Male; Pregnancy; Rabbits; Reproduction

1990